OSHU Cancer Institute, School of Medicine, Oregon Health and Science University, Portland, Oregon, USA grover@ohsu.edu and olsons@ohsu.edu
Epigenetic suppression of FANCF, a member of the Fanconi anemia gene family, is now implicated in some ovarian cancers. Might this suppression explain the sensitivity of such cancers to the cross-linking agent cisplatin (pages 568−574)?
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
